Chemical structure and sympathomimetic action of amines.
作者信息
Barger G, Dale H H
出版信息
J Physiol. 1910 Oct 11;41(1-2):19-59. doi: 10.1113/jphysiol.1910.sp001392.
Abstract
摘要
相似文献
1
Chemical structure and sympathomimetic action of amines.
J Physiol. 1910 Oct 11;41(1-2):19-59. doi: 10.1113/jphysiol.1910.sp001392.
2
The action of sympathomimetic amines on the central nervous system and the blood sugar; relation of chemical structure to mechanism of action.
J Pharmacol Exp Ther. 1950 Jan;98(1):62-71.
3
4
Sympathomimetic amines: the relation of structure to their action and inactivation.
Physiol Rev. 1946 Apr;26:169-97. doi: 10.1152/physrev.1946.26.2.169.
5
Excitatory action of sympathomimetic amines on 5-hydroxytryptamine receptors of gut.
Br J Pharmacol. 1969 Mar;35(3):383-93. doi: 10.1111/j.1476-5381.1969.tb08280.x.
6
Studies on the mechanism of action of sympathomimetic amines; the effect of various amines on the synthesis of cocarboxylase.
J Pharmacol Exp Ther. 1945 Oct;85:140-2.
7
Studies on the mechanism of action of sympathomimetic amines.
J Pharmacol Exp Ther. 1945 Oct;85:140-9.
8
The sympathomimetic vasodilating action of the aliphatic amines.
J Pharmacol Exp Ther. 1945 Nov;85:283-7.
9
The action of sympathomimetic amines on the isolated heart of the frog.
J Pharmacol Exp Ther. 1949 Aug;96(4 Pt. 1):365-71.
引用本文的文献
1
A Comparison of the Molecular Pharmacological Properties of Current Short, Long, and Ultra-Long-Acting β-Agonists Used for Asthma and COPD.
Pharmacol Res Perspect. 2025 Oct;13(5):e70154. doi: 10.1002/prp2.70154.
2
Reappraisal of the mechanism of cardiovascular responses to sympathomimetic amines in anaesthetised rats: dual α-adrenoceptor and trace amine receptor mechanisms.
Naunyn Schmiedebergs Arch Pharmacol. 2025 Mar;398(3):2627-2639. doi: 10.1007/s00210-024-03218-0. Epub 2024 Sep 6.
3
The role of the brain renin-angiotensin system in Parkinson´s disease.
Transl Neurodegener. 2024 Apr 15;13(1):22. doi: 10.1186/s40035-024-00410-3.
4
Evaluation of atherosclerosis as a risk factor in COPD patients by measuring the carotid intima-media thickness.
Cardiovasc Ultrasound. 2024 Jan 10;22(1):2. doi: 10.1186/s12947-023-00322-8.
5
The Molecular Blueprint for Chronic Obstructive Pulmonary Disease (COPD): A New Paradigm for Diagnosis and Therapeutics.
Oxid Med Cell Longev. 2023 Dec 21;2023:2297559. doi: 10.1155/2023/2297559. eCollection 2023.
6
Suggestion of creatine as a new neurotransmitter by approaches ranging from chemical analysis and biochemistry to electrophysiology.
Elife. 2023 Dec 21;12:RP89317. doi: 10.7554/eLife.89317.
7
Minding the gap: discovering the phenomenon of chemical transmission in the nervous system.
Hist Philos Life Sci. 2023 Oct 25;45(4):37. doi: 10.1007/s40656-023-00591-6.
8
L-DOPA-therapy in Parkinson's disease: some personal reflections on L-DOPA therapy from Vienna and Berlin.
J Neural Transm (Vienna). 2023 Nov;130(11):1323-1335. doi: 10.1007/s00702-023-02692-9. Epub 2023 Oct 5.
9
Asthma and COPD: A Focus on β-Agonists - Past, Present and Future.
Handb Exp Pharmacol. 2024;285:369-451. doi: 10.1007/164_2023_679.
10
Inflammatory Bowel Disease: Crosstalk between Histamine, Immunity, and Disease.
Int J Mol Sci. 2023 Jun 9;24(12):9937. doi: 10.3390/ijms24129937.
Zotero 插件